Form 4 for DYN Dyne Therapeutics, Inc.
Accepted 2024-02-28 00:00:00 ET · period of report 2024-02-28 · accession 0000950170-24-022242 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-02-28 | 2024-02-28 | DYN | Farwell Wildon | Chief Medical Off | S - Sale | $25.00 | -407 | 163.1K | -0.2% | -$10.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-28 | S | D | 407 | $25.00 | 163,096 | D | — | — | (F2) Includes 140,510 unvested RSUs. |